King Abdulaziz University

Mostafa H Ahmed

Abdelsattar Mansour Omar

Martin K Safo

Moustafa Elsayed El-Araby

Radwan S Elhaggar

Tamer M Abdelghany

A compound of formula (I), wherein Ris an optionally substituted aryl or an optionally substituted heteroaryl, Ris an optionally substituted aryl or an optionally substituted heteroaryl, and Ris an optionally substituted alkylamino, an optionally substituted cycloalkylamino, an optionally substituted arylamino, an optionally substituted heterocyclylamino, an optionally substituted heterocyclyl, and an optionally substituted dialkylamino. A pharmaceutical composition which includes the compound of formula (I) and a pharmaceutically acceptable carrier and/or excipient. A method of treating colorectal cancer in a subject, whereby a therapeutically effective amount of the compound of formula (I) is administered to the subject.

Method for making propenamide compound

Method of treating colorectal cancer

Bis-propenamide compounds and methods of treating cancer

Pharmaceutical composition with cytotoxic activity on colorectal cancer cells

Growing community of inventors

Jeddah, Saudi Arabia

Mostafa H Ahmed